| Pharmaceutical active ingredients: |
| Progesterone |
| Available forms, composition and doses of Nalutron: |
| N / A |
| Nalutron medical category: |
| Human:Oestrogens and progesterones and related synthetic drugsProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03DA04 - Progesterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nalitucsan | Nalidixic Acid | Unidentified Pharmaceutical Company |
| Nallin | Nalorphine | Unidentified Pharmaceutical Company |
| Nalline | Nalorphine | Unidentified Pharmaceutical Company |
| Nalurin | Nalidixic Acid | Unidentified Pharmaceutical Company |
| Nalutoral | Ethisterone | Unidentified Pharmaceutical Company |
| Namphen | Mefenamic Acid | Unidentified Pharmaceutical Company |
| Namuron | Cyclobarbital | Unidentified Pharmaceutical Company |
| Nandervit-N | Vitamin B3 | Unidentified Pharmaceutical Company |
| Nandrolin | Nandrolone Phenpropionate | Unidentified Pharmaceutical Company |
| Nanotaxel | Paclitaxel | Unidentified Pharmaceutical Company |